| SABS Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||
Below is a table of the SABS market cap history going back to 8/9/2021:
Also see: SABS Shares Outstanding History and SABS YTD Return |
SABS Market Cap History — SAB Biotherapeutics Capitalization Over Time
As of 5/6/2026 SAB Biotherapeutics has a market cap of 290.56 million. Investors often follow the SABS market cap history to compare the size of the company over time.
This page shows SABS market capitalization trends over time, with 19 market cap datapoints presented, dating back to 8/9/2021.
| SABS Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||
SABS Historical Market Cap: +15.42% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||
| SABS Stock Price Chart |
| About SAB Biotherapeutics Inc |
| SAB Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing fully human, multi-targeted, high-potency immunoglobulins (IgGs) without human donors or convalescent plasma to treat and prevent immune and autoimmune disorders. Its lead asset, SAB-142, targets type 1 diabetes with a disease-modifying approach. Using advanced genetic engineering, the company developed Transchromosomic (Tc) Bovine, the only transgenic animal with a human artificial chromosome, enabling the DiversitAb system to produce diverse, high-potency, fully-human IgGs for various unmet medical needs. We show 19 historical shares outstanding datapoints in our SABS shares outstanding history coverage, used to compute SABS market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SABS market cap history over the course of time is important for investors interested in comparing SABS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SABS versus a peer is one thing; comparing SABS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SABS can fluctuate over the course of history. With this page we aim to empower investors researching SABS by allowing them to research the SABS market cap history. |
| SABS Current Stock Quote |
Quotes delayed 20 minutes  Free SABS Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| SABS Share Performance |
| Market Cap Peers |
| SAB Biotherapeutics (SABS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
SAGE Market Cap History SANA Market Cap History SAVA Market Cap History SBFM Market Cap History SBPH Market Cap History SBTX Market Cap History SCPH Market Cap History SCPS Market Cap History SCTL Market Cap History SCYX Market Cap History More Healthcare companies » |
SABS Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
